Adding carbonic anhydrase inhibitor to prostaglandin therapy may yield less diurnal IOP fluctuation
Links shared publicly online about this topic.
- 809total visits
Adding carbonic anhydrase inhibitor to prostaglandin therapy may yield less diurnal IOP fluctuation
The addition of dorzolamide hydrochloride to therapy with bimatoprost may result in less diurnal IOP fluctuation and improve vascular resistance
View full resource at osnsupersite.com
Tags: Glaucoma, Glaucoma Medication, Intraocular Pressure Medication, Cosopt, Lumigan
Most Recently Shared on October 12, 2010 at 5:35 am By:
Adding carbonic anhydrase inhibitor to prostaglandin therapy may yield less diurnal IOP fluctuation: http://ht.ly/2RNly — #glaucoma
Advertisement
